BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sugimoto M, Zali MR, Yamaoka Y. The association of vacA genotypes and Helicobacter pylori-related gastroduodenal diseases in the Middle East. Eur J Clin Microbiol Infect Dis. 2009;28:1227-1236. [PMID: 19551413 DOI: 10.1007/s10096-009-0772-y] [Cited by in Crossref: 50] [Cited by in F6Publishing: 55] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Wattanawongdon W, Simawaranon Bartpho T, Tongtawee T. Relationship between Helicobacter pylori virulence genes and gastroduodenal disease. J Int Med Res 2023;51:3000605231161465. [PMID: 36924226 DOI: 10.1177/03000605231161465] [Reference Citation Analysis]
2 Karbalaei M, Talebi Bezmin Abadi A, Keikha M. Clinical relevance of the cagA and vacA s1m1 status and antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis. BMC Infect Dis 2022;22:573. [PMID: 35752757 DOI: 10.1186/s12879-022-07546-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Retnakumar R, Nath AN, Nair GB, Chattopadhyay S. Gastrointestinal microbiome in the context of Helicobacter pylori infection in stomach and gastroduodenal diseases. Progress in Molecular Biology and Translational Science 2022. [DOI: 10.1016/bs.pmbts.2022.07.001] [Reference Citation Analysis]
4 Khan S, Sharaf M, Ahmed I, Khan TU, Shabana S, Arif M, Kazmi SSUH, Liu C. Potential utility of nano-based treatment approaches to address the risk of Helicobacter pylori. Expert Rev Anti Infect Ther 2021;:1-18. [PMID: 34658307 DOI: 10.1080/14787210.2022.1990041] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
5 Alexander SM, Retnakumar RJ, Chouhan D, Devi TNB, Dharmaseelan S, Devadas K, Thapa N, Tamang JP, Lamtha SC, Chattopadhyay S. Helicobacter pylori in Human Stomach: The Inconsistencies in Clinical Outcomes and the Probable Causes. Front Microbiol 2021;12:713955. [PMID: 34484153 DOI: 10.3389/fmicb.2021.713955] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
6 Keikha M, Karbalaei M. EPIYA motifs of Helicobacter pylori cagA genotypes and gastrointestinal diseases in the Iranian population: a systematic review and meta-analysis. New Microbes New Infect 2021;41:100865. [PMID: 33912350 DOI: 10.1016/j.nmni.2021.100865] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
7 Keikha M, Ali-Hassanzadeh M, Karbalaei M. Association of Helicobacter pylori vacA genotypes and peptic ulcer in Iranian population: a systematic review and meta-analysis. BMC Gastroenterol 2020;20:266. [PMID: 32795257 DOI: 10.1186/s12876-020-01406-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
8 Keikha M. Is there a relationship between Helicobacter pylori vacA i1 or i2 alleles and development into peptic ulcer and gastric cancer? A meta-analysis study on an Iranian population. New Microbes New Infect 2020;36:100726. [PMID: 32714559 DOI: 10.1016/j.nmni.2020.100726] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
9 Deng L, He XY, Tang B, Xiang Y, Yue JJ. An improved quantitative real-time polymerase chain reaction technology for Helicobacter pylori detection in stomach tissue and its application value in clinical precision testing. BMC Biotechnol 2020;20:33. [PMID: 32571272 DOI: 10.1186/s12896-020-00624-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
10 Sugimoto M, Murata M, Yamaoka Y. Chemoprevention of gastric cancer development after Helicobacter pylori eradication therapy in an East Asian population: Meta-analysis. World J Gastroenterol 2020; 26(15): 1820-1840 [PMID: 32351296 DOI: 10.3748/wjg.v26.i15.1820] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
11 Alsulaimany FAS, Awan ZA, Almohamady AM, Koumu MI, Yaghmoor BE, Elhady SS, Elfaky MA. Prevalence of Helicobacter pylori Infection and Diagnostic Methods in the Middle East and North Africa Region. Medicina (Kaunas) 2020;56:E169. [PMID: 32283700 DOI: 10.3390/medicina56040169] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
12 Guillermo Espinoza-Contreras J, Idalia Torres-Ruiz M, Ariel Waller-González L, De Jesús Ramírez-García J, Torres-López J, Ventura-Juárez J, Verónica Moreno-Córdova E, Ernesto López-Ramos J, Humberto Muñoz-Ortega M, Eugenia Vargas-Camaño M, González-Segovia R. Immunological markers and Helicobacter pylori in patients with stomach cancer: Expression and correlation. Biomed Rep 2020;12:233-43. [PMID: 32257186 DOI: 10.3892/br.2020.1285] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Bakhti SZ, Latifi-Navid S, Zahri S. Unique constellations of five polymorphic sites of Helicobacter pylori vacA and cagA status associated with risk of gastric cancer. Infect Genet Evol 2020;79:104167. [PMID: 31891782 DOI: 10.1016/j.meegid.2019.104167] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
14 Ofori EG, Adinortey CA, Bockarie AS, Kyei F, Tagoe EA, Adinortey MB. Helicobacter pylori Infection, Virulence Genes' Distribution and Accompanying Clinical Outcomes: The West Africa Situation. Biomed Res Int 2019;2019:7312908. [PMID: 31886245 DOI: 10.1155/2019/7312908] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
15 Chmiela M, Walczak N, Rudnicka K. Helicobacter pylori outer membrane vesicles involvement in the infection development and Helicobacter pylori-related diseases. J Biomed Sci 2018;25:78. [PMID: 30409143 DOI: 10.1186/s12929-018-0480-y] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 5.6] [Reference Citation Analysis]
16 Chang WL, Yeh YC, Sheu BS. The impacts of H. pylori virulence factors on the development of gastroduodenal diseases. J Biomed Sci. 2018;25:68. [PMID: 30205817 DOI: 10.1186/s12929-018-0466-9] [Cited by in Crossref: 71] [Cited by in F6Publishing: 76] [Article Influence: 14.2] [Reference Citation Analysis]
17 Pucułek M, Machlowska J, Wierzbicki R, Baj J, Maciejewski R, Sitarz R. Helicobacter pylori associated factors in the development of gastric cancer with special reference to the early-onset subtype. Oncotarget 2018;9:31146-62. [PMID: 30123433 DOI: 10.18632/oncotarget.25757] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 6.2] [Reference Citation Analysis]
18 Sugimoto M, Yasuda H, Andoh A. Nutrition status and Helicobacter pylori infection in patients receiving hemodialysis. World J Gastroenterol 2018; 24(15): 1591-1600 [PMID: 29686466 DOI: 10.3748/wjg.v24.i15.1591] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
19 Abu-Taleb AMF, Abdelattef RS, Abdel-Hady AA, Omran FH, El-Korashi LA, Abdel-Aziz El-Hady H, El-Gebaly AM. Prevalence of Helicobacter pylori cagA and iceA Genes and Their Association with Gastrointestinal Diseases. Int J Microbiol. 2018;2018:4809093. [PMID: 29849647 DOI: 10.1155/2018/4809093] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
20 Pormohammad A, Ghotaslou R, Leylabadlo HE, Nasiri MJ, Dabiri H, Hashemi A. Risk of gastric cancer in association with Helicobacter pylori different virulence factors: A systematic review and meta-analysis. Microb Pathog. 2018;118:214-219. [PMID: 29510208 DOI: 10.1016/j.micpath.2018.03.004] [Cited by in Crossref: 50] [Cited by in F6Publishing: 38] [Article Influence: 10.0] [Reference Citation Analysis]
21 Al-Maleki AR, Loke MF, Lui SY, Ramli NSK, Khosravi Y, Ng CG, Venkatraman G, Goh KL, Ho B, Vadivelu J. Helicobacter pylori outer inflammatory protein A (OipA) suppresses apoptosis of AGS gastric cells in vitro. Cell Microbiol 2017;19. [PMID: 28776327 DOI: 10.1111/cmi.12771] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
22 Wang D, Li Q, Gong Y, Yuan Y. The association between vacA or cagA status and eradication outcome of Helicobacter pylori infection: A meta-analysis. PLoS One. 2017;12:e0177455. [PMID: 28493953 DOI: 10.1371/journal.pone.0177455] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
23 Wang Y, Lin T, Shang S, Chen H, Kao C, Wu C, Yang T. Helicobacter pylori infection increases the risk of adult-onset asthma: a nationwide cohort study. Eur J Clin Microbiol Infect Dis 2017;36:1587-94. [DOI: 10.1007/s10096-017-2972-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
24 Fahimi F, Tohidkia MR, Fouladi M, Aghabeygi R, Samadi N, Omidi Y. Pleiotropic cytotoxicity of VacA toxin in host cells and its impact on immunotherapy. Bioimpacts 2017;7:59-71. [PMID: 28546954 DOI: 10.15171/bi.2017.08] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
25 El Khadir M, Alaoui Boukhris S, Benajah DA, El Rhazi K, Ibrahimi SA, El Abkari M, Harmouch T, Nejjari C, Mahmoud M, Benlemlih M, Bennani B. VacA and CagA Status as Biomarker of Two Opposite End Outcomes of Helicobacter pylori Infection (Gastric Cancer and Duodenal Ulcer) in a Moroccan Population. PLoS One. 2017;12:e0170616. [PMID: 28125638 DOI: 10.1371/journal.pone.0170616] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
26 Valadan Tahbaz S, Yadegar A, Amirmozafari N, Yaghoobee S, Ehsani Ardakani MJ, Zojaji H. Occurrence of Helicobacter pylori and its major virulence genotypes in dental plaque samples of patients with chronic periodontitis in Iran. Gastroenterol Hepatol Bed Bench 2017;10:S70-8. [PMID: 29511475] [Reference Citation Analysis]
27 Bakhti SZ, Latifi-Navid S, Mohammadi S, Zahri S, Bakhti FS, Feizi F, Yazdanbod A, Siavoshi F. Relevance of Helicobacter pylori vacA 3'-end Region Polymorphism to Gastric Cancer. Helicobacter 2016;21:305-16. [PMID: 26612250 DOI: 10.1111/hel.12284] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
28 Thi Huyen Trang T, Thanh Binh T, Yamaoka Y. Relationship between vacA Types and Development of Gastroduodenal Diseases. Toxins (Basel) 2016;8:E182. [PMID: 27294955 DOI: 10.3390/toxins8060182] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
29 Suzuki H, Mori H. Different Pathophysiology of Gastritis between East and West? An Asian Perspective. Inflamm Intest Dis 2016;1:123-8. [PMID: 29922667 DOI: 10.1159/000446301] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
30 Pinto-Ribeiro I, Ferreira RM, Batalha S, Hlaing T, Wong SI, Carneiro F, Figueiredo C. Helicobacter pylori vacA Genotypes in Chronic Gastritis and Gastric Carcinoma Patients from Macau, China. Toxins (Basel) 2016;8:E142. [PMID: 27164143 DOI: 10.3390/toxins8050142] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
31 Matsunari O, Miftahussurur M, Shiota S, Suzuki R, Vilaichone RK, Uchida T, Ratanachu-ek T, Tshering L, Mahachai V, Yamaoka Y. Rare Helicobacter pylori Virulence Genotypes in Bhutan. Sci Rep 2016;6:22584. [PMID: 26931643 DOI: 10.1038/srep22584] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
32 Ahn HJ, Lee DS. Helicobacter pylori in gastric carcinogenesis. World J Gastrointest Oncol 2015; 7(12): 455-465 [PMID: 26690981 DOI: 10.4251/wjgo.v7.i12.455] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 60] [Article Influence: 6.5] [Reference Citation Analysis]
33 da Costa DM, Pereira EDS, Rabenhorst SHB. What exists beyond cagA and vacA? Helicobacter pylori genes in gastric diseases. World J Gastroenterol 2015; 21(37): 10563-10572 [PMID: 26457016 DOI: 10.3748/wjg.v21.i37.10563] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
34 Wang MY, Liu XF, Gao XZ. Helicobacter pylori virulence factors in development of gastric carcinoma. Future Microbiol. 2015;10:1505-1516. [PMID: 26346770 DOI: 10.2217/fmb.15.72] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
35 Yamaoka Y, Graham DY. Helicobacter pylori virulence and cancer pathogenesis. Future Oncol. 2014;10:1487-1500. [PMID: 25052757 DOI: 10.2217/fon.14.29] [Cited by in Crossref: 90] [Cited by in F6Publishing: 97] [Article Influence: 11.3] [Reference Citation Analysis]
36 Miftahussurur M, Yamaoka Y. Helicobacter pylori virulence genes and host genetic polymorphisms as risk factors for peptic ulcer disease. Expert Rev Gastroenterol Hepatol 2015;9:1535-47. [PMID: 26470920 DOI: 10.1586/17474124.2015.1095089] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
37 Ishaq S, Nunn L. Helicobacter pylori and gastric cancer: a state of the art review. Gastroenterol Hepatol Bed Bench 2015;8:S6-S14. [PMID: 26171139] [Reference Citation Analysis]
38 Ferreira RM, Machado JC, Figueiredo C. Clinical relevance of Helicobacter pylori vacA and cagA genotypes in gastric carcinoma. Best Pract Res Clin Gastroenterol 2014;28:1003-15. [PMID: 25439067 DOI: 10.1016/j.bpg.2014.09.004] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 5.1] [Reference Citation Analysis]
39 Shiota S, Cruz M, Abreu JAJ, Mitsui T, Terao H, Disla M, Iwatani S, Nagashima H, Matsuda M, Uchida T, Tronilo L, Rodríguez E, Yamaoka Y. Virulence genes of Helicobacter pylori in the Dominican Republic. J Med Microbiol 2014;63:1189-96. [PMID: 24965801 DOI: 10.1099/jmm.0.075275-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
40 Kariya S, Okano M, Nishizaki K. An association between Helicobacter pylori and upper respiratory tract disease: Fact or fiction? World J Gastroenterol 2014; 20(6): 1470-1484 [PMID: 24587622 DOI: 10.3748/wjg.v20.i6.1470] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
41 Panic N, Mastrostefano E, Leoncini E, Persiani R, Arzani D, Amore R, Ricci R, Sicoli F, Sioletic S, Bulajic M, D' Ugo D, Ricciardi W, Boccia S. Susceptibility to Helicobacter pylori infection: results of an epidemiological investigation among gastric cancer patients. Mol Biol Rep 2014;41:3637-50. [PMID: 24526578 DOI: 10.1007/s11033-014-3228-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
42 Havaei SA, Mohajeri P, Khashei R, Salehi R, Tavakoli H. Prevalence of Helicobacter pylori vacA different genotypes in Isfahan, Iran. Adv Biomed Res 2014;3:48. [PMID: 24627856 DOI: 10.4103/2277-9175.125761] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
43 Qadri Q, Afroze D, Rasool R, Gulzar G, Naqash S, Siddiqi MA, Shah ZA. CagA subtyping in Helicobacter pylori isolates from gastric cancer patients in an ethnic Kashmiri population. Microbial Pathogenesis 2014;66:40-3. [DOI: 10.1016/j.micpath.2013.12.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
44 Matos JI, de Sousa HA, Marcos-Pinto R, Dinis-Ribeiro M. Helicobacter pylori CagA and VacA genotypes and gastric phenotype: a meta-analysis. Eur J Gastroenterol Hepatol 2013;25:1431-41. [PMID: 23929249 DOI: 10.1097/MEG.0b013e328364b53e] [Cited by in Crossref: 79] [Cited by in F6Publishing: 80] [Article Influence: 7.9] [Reference Citation Analysis]
45 Vaziri F, Peerayeh SN, Alebouyeh M, Mirzaei T, Yamaoka Y, Molaei M, Maghsoudi N, Zali MR. Diversity of Helicobacter pylori genotypes in Iranian patients with different gastroduodenal disorders. World J Gastroenterol 2013; 19(34): 5685-5692 [PMID: 24039362 DOI: 10.3748/wjg.v19.i34.5685] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
46 Shiota S, Suzuki R, Yamaoka Y. The significance of virulence factors in Helicobacter pylori. J Dig Dis 2013;14:341-9. [PMID: 23452293 DOI: 10.1111/1751-2980.12054] [Cited by in Crossref: 86] [Cited by in F6Publishing: 90] [Article Influence: 8.6] [Reference Citation Analysis]
47 Deng B, Li Y, Zhang Y, Bai L, Yang P. Helicobacter pylori infection and lung cancer: a review of an emerging hypothesis. Carcinogenesis. 2013;34:1189-1195. [PMID: 23568955 DOI: 10.1093/carcin/bgt114] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
48 Sahara S, Sugimoto M, Vilaichone RK, Mahachai V, Miyajima H, Furuta T, Yamaoka Y. Role of Helicobacter pylori cagA EPIYA motif and vacA genotypes for the development of gastrointestinal diseases in Southeast Asian countries: a meta-analysis. BMC Infect Dis. 2012;12:223. [PMID: 22994150 DOI: 10.1186/1471-2334-12-223] [Cited by in Crossref: 64] [Cited by in F6Publishing: 67] [Article Influence: 5.8] [Reference Citation Analysis]
49 Yamaoka Y. Pathogenesis of Helicobacter pylori-Related Gastroduodenal Diseases from Molecular Epidemiological Studies. Gastroenterol Res Pract. 2012;2012:371503. [PMID: 22829807 DOI: 10.1155/2012/371503] [Cited by in Crossref: 50] [Cited by in F6Publishing: 56] [Article Influence: 4.5] [Reference Citation Analysis]
50 Hosseini E, Poursina F, de Wiele TV, Safaei HG, Adibi P. Helicobacter pylori in Iran: A systematic review on the association of genotypes and gastroduodenal diseases. J Res Med Sci 2012;17:280-92. [PMID: 23267382] [Reference Citation Analysis]
51 Watada M, Shiota S, Matsunari O, Suzuki R, Murakami K, Fujioka T, Yamaoka Y. Association between Helicobacter pylori cagA-related genes and clinical outcomes in Colombia and Japan. BMC Gastroenterol. 2011;11:141. [PMID: 22189161 DOI: 10.1186/1471-230x-11-141] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
52 Matsunari O, Shiota S, Suzuki R, Watada M, Kinjo N, Murakami K, Fujioka T, Kinjo F, Yamaoka Y. Association between Helicobacter pylori virulence factors and gastroduodenal diseases in Okinawa, Japan. J Clin Microbiol 2012;50:876-83. [PMID: 22189111 DOI: 10.1128/JCM.05562-11] [Cited by in Crossref: 77] [Cited by in F6Publishing: 79] [Article Influence: 6.4] [Reference Citation Analysis]
53 Suzuki R, Shiota S, Yamaoka Y. Molecular epidemiology, population genetics, and pathogenic role of Helicobacter pylori. Infect Genet Evol. 2012;12:203-213. [PMID: 22197766 DOI: 10.1016/j.meegid.2011.12.002] [Cited by in Crossref: 104] [Cited by in F6Publishing: 114] [Article Influence: 8.7] [Reference Citation Analysis]
54 Jung SW, Sugimoto M, Shiota S, Graham DY, Yamaoka Y. The intact dupA cluster is a more reliable Helicobacter pylori virulence marker than dupA alone. Infect Immun. 2012;80:381-387. [PMID: 22038914 DOI: 10.1128/iai.05472-11] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 4.8] [Reference Citation Analysis]
55 Siavoshi F, Asgharzadeh A, Ghadiri H, Massarrat S, Latifi-Navid S, Zamani M. Helicobacter pylori genotypes and types of gastritis in first-degree relatives of gastric cancer patients. Int J Med Microbiol 2011;301:506-12. [PMID: 21641279 DOI: 10.1016/j.ijmm.2011.03.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
56 Yamaoka Y. Mechanisms of disease: Helicobacter pylori virulence factors. Nat Rev Gastroenterol Hepatol 2010;7:629-41. [PMID: 20938460 DOI: 10.1038/nrgastro.2010.154] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
57 Yamaoka Y. Mechanisms of disease: Helicobacter pylori virulence factors. Nat Rev Gastroenterol Hepatol 2010;7:629-41. [PMID: 20938460 DOI: 10.1038/nrgastro.2010.154] [Cited by in Crossref: 420] [Cited by in F6Publishing: 434] [Article Influence: 32.3] [Reference Citation Analysis]
58 Douraghi M, Talebkhan Y, Zeraati H, Mohammadi M. Cooperative genotyping for Helicobacter pylori virulence determinants strengthens the predictive value of gastric cancer risk assessment. Dig Liver Dis 2010;42:662-3. [PMID: 20172771 DOI: 10.1016/j.dld.2010.01.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
59 Hussein NR. Helicobacter pylori and gastric cancer in the Middle East: A new enigma? World J Gastroenterol 2010; 16(26): 3226-3234 [PMID: 20614477 DOI: 10.3748/wjg.v16.i26.3226] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 43] [Article Influence: 2.9] [Reference Citation Analysis]
60 Schmidt HM, Andres S, Nilsson C, Kovach Z, Kaakoush NO, Engstrand L, Goh KL, Fock KM, Forman D, Mitchell H. The cag PAI is intact and functional but HP0521 varies significantly in Helicobacter pylori isolates from Malaysia and Singapore. Eur J Clin Microbiol Infect Dis. 2010;29:439-451. [PMID: 20157752 DOI: 10.1007/s10096-010-0881-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]